JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Selling, General & Administrative
JW (Cayman) Therapeutics Co Ltd
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Selling, General & Administrative
-¥178.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Selling, General & Administrative
-¥8.8B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Selling, General & Administrative
-¥3.9B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Selling, General & Administrative
-¥1.9B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Selling, General & Administrative
-¥3.7B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-30%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Selling, General & Administrative
-¥281.4m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-178.4m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Selling, General & Administrative amounts to -178.4m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-34%
Over the last year, the Selling, General & Administrative growth was 51%. The average annual Selling, General & Administrative growth rates for JW (Cayman) Therapeutics Co Ltd have been 10% over the past three years , -34% over the past five years .